| Sign In to gain access to subscriptions and/or personal tools. |
Role of ß2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune diseaseLaboratory of Immunology, Brest University Medical School, BP 824, F29 609 Brest
Department of Internal Medicine, La Pitié-Salpétrière Hospital, Paris
Laboratory of Immunology, Brest University Medical School, BP 824, F29 609 Brest
Laboratory of Immunology, Brest University Medical School, BP 824, F29 609 Brest
Begin Hospital, Saint Mandé, France
Department of Internal Medicine, Brest University Medical School, BP 824, F29 609 Brest Cedex
Laboratory of Immunology, Brest University Medical School, BP 824, F29 609 Brest The binding capacity to cardiolipin and the functional affinity of affinity-purified anticardiolipin (aCL) IgG of patients with autoimmune disease have been compared with those of individuals with malaria and acquired immunodeficiency syndrome (AIDS). The binding of autoimmune IgG aCL was enhanced gradually by the incorporation of increasing amounts of ß2-glycoprotein I (ß2GPI) into the assay, in contrast to that of patients with infectious diseases. In addition, there were significant reductions of functional affinity in autoimmune disease, but not in malaria or in AIDS. These results indicate that ß2GPI requirement for binding to the target antigen varies inversely with functional affinity in autoimmune disease when ß 2GPI was present, and suggest that IgG aCL are more heterogeneous in this type of disorder than in patients with infectious disease.
Key Words: anticardiolipin antibody ß2-glycoprotein I functional affinity
Lupus, Vol. 4, No. 6,
477-481 (1995) This article has been cited by other articles:
|
|||||||||||||||
